These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24270364)

  • 21. Adherence of trials of operative intervention to the CONSORT statement.
    Carthy ER; Agha R; Gray R; Sullivan M; Altman DG; Gordon-Weeks AN
    Ann R Coll Surg Engl; 2014 Jan; 96(1):86. PubMed ID: 24417849
    [No Abstract]   [Full Text] [Related]  

  • 22. [Randomized clinical trials (CONSORT)].
    Cobos-Carbó A;
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():21-7. PubMed ID: 16464423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SOP 10: Study report and publication.
    Onkologie; 2003 Oct; 26 Suppl 6():48-9. PubMed ID: 23570187
    [No Abstract]   [Full Text] [Related]  

  • 24. Standards for Reporting Research Results: Implications for the Field of Health Education.
    Kegler MC; Allegrante JP
    Health Educ Behav; 2016 Oct; 43(5):497-500. PubMed ID: 27624440
    [No Abstract]   [Full Text] [Related]  

  • 25. Quality, scope and reporting standards of randomised controlled trials in Irish Health Research: an observational study.
    Clyne B; Boland F; Murphy N; Murphy E; Moriarty F; Barry A; Wallace E; Devine T; Smith SM; Devane D; Murphy A; Fahey T
    Trials; 2020 Jun; 21(1):494. PubMed ID: 32513240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Evidence From the Randomized Controlled Trials Rehabilitation Checklist (RCTRACK) reporting guideline project.
    Negrini S; Chan L; Ferriero G; Frontera WR; Heinemann AW
    Arch Phys Med Rehabil; 2021 Aug; 102(8):1665-1667. PubMed ID: 33991486
    [No Abstract]   [Full Text] [Related]  

  • 27. Re: Quality of reporting of modern randomized controlled trials in medical oncology: a systematic review.
    Palys KE; Berger VW
    J Natl Cancer Inst; 2013 Feb; 105(3):244-5. PubMed ID: 23334222
    [No Abstract]   [Full Text] [Related]  

  • 28. [Consistency in the analysis and reporting of PEPs in oncology randomized controlled trials from registration to publication: a systematic review].
    Boespflug A; Gan H; Chen EX; Pond G; You B
    Bull Cancer; 2012 Oct; 99(10):943-52. PubMed ID: 23034429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving the reporting of randomised trials: the CONSORT Statement and beyond.
    Altman DG; Moher D; Schulz KF
    Stat Med; 2012 Nov; 31(25):2985-97. PubMed ID: 22903776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Non-randomized evaluation studies (TREND)].
    Vallvé C; Artés M; Cobo E;
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():38-42. PubMed ID: 16464426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CONSORT statement: extension to cluster randomised trials.
    Campbell MK; Elbourne DR; Altman DG;
    BMJ; 2004 Mar; 328(7441):702-8. PubMed ID: 15031246
    [No Abstract]   [Full Text] [Related]  

  • 32. Low quality of reporting adverse drug reactions in paediatric randomised controlled trials.
    de Vries TW; van Roon EN
    Arch Dis Child; 2010 Dec; 95(12):1023-6. PubMed ID: 20551194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Randomized Controlled Trials Rehabilitation Checklist: Methodology of Development of a Reporting Guideline Specific to Rehabilitation.
    Negrini S; Armijo-Olivo S; Patrini M; Frontera WR; Heinemann AW; Machalicek W; Whyte J; Arienti C;
    Am J Phys Med Rehabil; 2020 Mar; 99(3):210-215. PubMed ID: 31851008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.
    Orkin AM; Gill PJ; Ghersi D; Campbell L; Sugarman J; Emsley R; Steg PG; Weijer C; Simes J; Rombey T; Williams HC; Wittes J; Moher D; Richards DP; Kasamon Y; Getz K; Hopewell S; Dickersin K; Wu T; Ayala AP; Schulz KF; Calleja S; Boutron I; Ross JS; Golub RM; Khan KM; Mulrow C; Siegfried N; Heber J; Lee N; Kearney PR; Wanyenze RK; Hróbjartsson A; Williams R; Bhandari N; Jüni P; Chan AW;
    JAMA; 2021 Jul; 326(3):257-265. PubMed ID: 34152382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of tailored subheadings was successful in enhancing compliance with CONSORT in a dental journal.
    Koletsi D; Fleming PS; Behrents RG; Lynch CD; Pandis N
    J Dent; 2017 Dec; 67():66-71. PubMed ID: 28941813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial: Reporting Clinical Trials with Important Modifications Due to Extenuating Circumstances, Including the COVID-19 Pandemic: CONSERVE 2021.
    Parums DV
    Med Sci Monit; 2021 Aug; 27():e934514. PubMed ID: 34456331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CONSORT 2010.
    Lancet; 2010 Apr; 375(9721):1136. PubMed ID: 20338630
    [No Abstract]   [Full Text] [Related]  

  • 38. The value of randomized clinical trials in ophthalmology.
    Chew EY
    Am J Ophthalmol; 2011 Apr; 151(4):575-8. PubMed ID: 21420522
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluating single-incision slings in female stress urinary incontinence: the usefulness of the CONSORT statement criteria.
    Diallo S; Cour F; Josephson A; Vidart A; Botto H; Lebret T; Bonan B
    Urology; 2012 Sep; 80(3):535-41. PubMed ID: 22925231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacy journal abstracts published in PubMed that abide by the CONsolidated Standards Of Reporting Trials (CONSORT) guidelines.
    Blair DA; Hughes PJ; Woolley TW
    J Med Libr Assoc; 2014 Apr; 102(2):110-4. PubMed ID: 24860268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.